AFRIPOX - A One Health approach of monkeypox in Central African Republic

  • Funded by Institut Pasteur International Network (IPIN)
  • Total publications:0 publications

Grant number: 143621

Grant search

Key facts

  • Disease

    mpox
  • Start & end year

    2020
    2023
  • Funder

    Institut Pasteur International Network (IPIN)
  • Principal Investigator

    N/A

  • Research Location

    Central African Republic
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Animal and environmental research and research on diseases vectors

  • Research Subcategory

    Animal source and routes of transmission

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

  • Mpox Research Priorities

    Epidemiological studies

  • Mpox Research Sub Priorities

    Epidemiology & transmission dynamics of mpox including sexual transmission.

Abstract

About Monkeypox is an emerging Orthopoxvirus responsible for monkeypox disease, clinically similar to smallpox with a lethality of around 1 to 10%. This disease is a zoonosis initially transmitted from an animal reservoir and then spread by human-to-human and nosocomial transmission. Monkeypox has been designated by the 2018 WHO Research and Development Blueprint as an emerging disease requiring accelerated research and development of public health actions. However, little is known about this virus, its animal reservoir, the risk factors for human involvement, and the ecological and social factors that contribute to its emergence. There is no specific treatment or vaccine against monkeypox. However, the immunity given by smallpox vaccination would provide cross-immunity against monkeypox virus infection. Our project will piggyback on the national monkeypox surveillance process and will allow a holistic approach to this disease in CAR through multiple complementary approaches. This project will characterize animal reservoirs of monkeypox viruses and their ecological habitats, and will shed light on the interactions between humans and these reservoirs to identify practices that can prevent zoonotic viral transmission. Through the study of past and ongoing epidemics, we will document the epidemic potential of the disease and the risk factors associated with human-to-human transmission, with the aim of improving control measures during epidemics. At the same time, the project will characterize the ecological zones favorable to the occurrence of monkeypox epidemics in Central Africa and the recent changes characterizing these zones. Finally, the project will contribute to the reinforcement of local capacities (laboratory diagnosis, field and sequencing capacities, and infection prevention and control (IPC) capacities) in a region that experiences frequent viral emergences. The interest of this project lies in a preventive management of these potential emergences in a generic way by understanding their epidemiology and the factors involved in their emergence, and the importance of strengthening the health and surveillance systems of the countries concerned. New article 2022: https://theconversation.com/monkeypox-this-circulation-of-the-disease-is-completely-new-183517?utm_source=twitter&utm_medium=bylinetwitterbutton Other articles: https://www.linkedin.com/posts/institut-pasteur-bangui_monkeypox-centrafrique-activity-6905146708620050432-0YOX https://pasteur-bangui.org/14-january-2020-afripox-le-projet-des-instituts-pasteur-pour-contrer-le-monkeypox-en-republique-centrafricaine/https://pasteur-bangui. org/14-january-2020-afripox-the-pasteur-instituts-project-to-counter-monkeypox-in-the-central-african-republic/ https://pasteur-bangui.org/10-october-2018-monkeypox-en-republique-centrafricaine-lheure-est-a-la-prevention/